Simplex Trading, LLC Medicinova Inc Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$1.28 - $1.57 $497 - $610	-389 Reduced 88.21%	52 $0
Q1 2024 Apr 25, 2024	BUY	$1.28 - $1.65 $285 - $367	223 Added 102.29%	441 $0
Q4 2023 Feb 02, 2024	BUY	$1.38 - $2.06 $300 - $449	218 New	218 $0
Q3 2022 Nov 04, 2022	SELL	$2.1 - $2.6 $317 - $392	-151 Reduced 77.44%	44 $0
Q1 2022 May 02, 2022	SELL	$2.19 - $2.81 $29,615 - $37,999	-13,523 Reduced 98.58%	195 $0
Q3 2021 Oct 28, 2021	SELL	$3.4 - $4.24 $3,400 - $4,240	-1,000 Reduced 6.79%	13,718 $56,000
Q2 2021 Aug 12, 2021	BUY	$3.76 - $5.14 $55,339 - $75,650	14,718 New	14,718 $62,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.